Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +51.4% | +168.2% | 3 / 3 | -10.1% | +2.68 pp | +3.55 pp | +22.6% | 0.46 | 3.22 | 3.620 | −10,1% | 366 | +38,6% | 3.22 | 11.69 | −72,4% |
| Pts | 8 | 12 | 12 | 0 | 8 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 18.300 (close price on 2026-10-19)EPS (TTM): 5.680
Financial charts
1.Revenue & growth
VND bn3.613Q2/26
1.Revenue & growth
VND bn3.613Q2/26
2.Profit & growth
VND bn182Q2/26
3.Profit mix (Penman)
VND bn1.963Q2/26
4.Margins & cost structure
%21.3%Q2/26
5.Returns & cash cycle
% · days15.8%Q2/26
6.Earnings quality & cash
VND bn5.560Q2/26
7.Asset structure
VND bn16.657Q2/26
8.Funding & debt health
VND bn · times16.657Q2/26
9.Revenue backlog
VND bn42,1Q2/26
10.Valuation
times · %3,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %706Q2/26
Adjusted EPS growth, latest quarter
31.7%
Average adjusted EPS growth, 3 quarters
162%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.6%
Source: vnstockData through Q2/26